20 Mar 2023 Bionest FDA Finalizes Guidance on Multiple Endpoints in Clinical Trials Assessing multiple endpoints in clinical trial results can prove challenging, prompting the FDA to provide new guidance for drug sponsors.
13 Mar 2023 Bionest Alzheimer’s Disease Update Part 2: The Importance of Amyloid and Its Clearance in AD Could cellular waste management be key in treating Alzheimer's Disease? We explore this emerging field of research and potential for new AD drugs.